Autoimmune Disease Therapeutics Market to Reach US$ 110.8 Billion by 2033, Exhibiting 7.4% CAGR
Shifts in treatment paradigms and advances in biologics propel strategic opportunities in the autoimmune disease therapeutics market.
Global **Autoimmune Disease Therapeutics Market Overview
The autoimmune disease therapeutics market is currently positioned as a critical segment within the global pharmaceutical landscape, addressing a wide spectrum of chronic and debilitating conditions. As of 2026, the market is valued at US$ 67.2 billion, reflecting sustained demand for innovative therapies targeting diseases